{"id":50031,"date":"2021-03-10T16:01:21","date_gmt":"2021-03-10T21:01:21","guid":{"rendered":"https:\/\/www.med.unc.edu\/medicine\/?p=50031"},"modified":"2023-06-06T18:07:17","modified_gmt":"2023-06-06T22:07:17","slug":"ridgeback-merck-announce-preliminary-data-of-potential-covid-19-therapeutic","status":"publish","type":"post","link":"https:\/\/www.med.unc.edu\/medicine\/news\/ridgeback-merck-announce-preliminary-data-of-potential-covid-19-therapeutic\/","title":{"rendered":"Ridgeback, Merck Announce Preliminary Data of Potential COVID-19 Therapeutic"},"content":{"rendered":"<p><em>The findings reported on a secondary objective to reduce time to negative test result of infectious SARS-CoV-2 virus in individuals with symptomatic COVID-19. UNC School of Medicine\u2019s William Fischer, MD, is the lead investigator on the study of Molnupiravir, the investigational drug also known as EIDD-2801.<\/em><\/p>\n<hr \/>\n<figure id=\"attachment_5986\" class=\"thumbnail wp-caption alignright\" style=\"width: 270px\"><img loading=\"lazy\" decoding=\"async\" class=\"size-medium wp-image-5986\" src=\"https:\/\/www.med.unc.edu\/medicine\/wp-content\/uploads\/sites\/945\/2018\/12\/william-fischer-260x300.jpeg\" alt=\"\" width=\"260\" height=\"300\" srcset=\"https:\/\/www.med.unc.edu\/medicine\/wp-content\/uploads\/sites\/945\/2018\/12\/william-fischer-260x300.jpeg 260w, https:\/\/www.med.unc.edu\/medicine\/wp-content\/uploads\/sites\/945\/2018\/12\/william-fischer-301x347.jpeg 301w, https:\/\/www.med.unc.edu\/medicine\/wp-content\/uploads\/sites\/945\/2018\/12\/william-fischer.jpeg 347w\" sizes=\"auto, (max-width: 260px) 100vw, 260px\" \/><figcaption class=\"caption wp-caption-text\">William Fischer, MD<\/figcaption><\/figure>\n<p>Merck and Ridgeback Biotherapeutics announced preliminary results from Ridgeback\u2019s Phase 2a randomized, double-blinded, placebo-controlled trial to evaluate the safety, tolerability, and efficacy to eliminate SARS-CoV-2 viral RNA of molnupiravir (EIDD-2801\/MK-4482), an investigational oral antiviral agent.<\/p>\n<p>The companies today reported findings on one secondary objective from the Phase 2a study, showing a reduction in time (days) to negativity of infectious virus isolation in nasopharyngeal swabs from participants with symptomatic SARS-CoV-2 infection. Findings from the primary efficacy and safety endpoints and additional secondary objectives will be presented at an upcoming medical meeting.<\/p>\n<p>\u201cThe secondary objective findings in this study, of a quicker decrease in infectious virus among individuals with early COVID-19 treated with molnupiravir, are promising and if supported by additional studies, could have important public health implications, particularly as the SARS-CoV-2 virus continues to spread and evolve globally,\u201d said William Fischer, MD, lead investigator of the EIDD-2801 2003 study and associate professor in the UNC Division of Pulmonary Diseases and Critical Care Medicine at the University of North Carolina School of Medicine.<\/p>\n<p>Read more from the <a href=\"https:\/\/news.unchealthcare.org\/2021\/03\/ridgeback-merck-announce-preliminary-data-of-potential-covid-19-therapeutic\/\">UNC Health and UNC School of Medicine Newsroom<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>The findings reported on a secondary objective to reduce time to negative test result of infectious SARS-CoV-2 virus in individuals with symptomatic COVID-19. UNC School of Medicine\u2019s William Fischer, MD, is the lead investigator on the study of Molnupiravir, the investigational drug also known as EIDD-2801. Merck and Ridgeback Biotherapeutics announced preliminary results from Ridgeback\u2019s &hellip; <a href=\"https:\/\/www.med.unc.edu\/medicine\/news\/ridgeback-merck-announce-preliminary-data-of-potential-covid-19-therapeutic\/\" aria-label=\"Read more about Ridgeback, Merck Announce Preliminary Data of Potential COVID-19 Therapeutic\">Read more<\/a><\/p>\n","protected":false},"author":69419,"featured_media":5986,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"layout":"","cellInformation":"","apiCallInformation":"","footnotes":"","_links_to":"","_links_to_target":""},"categories":[2,102],"tags":[630],"class_list":["post-50031","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","category-pulmonary","tag-630","odd"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Ridgeback, Merck Announce Preliminary Data of Potential COVID-19 Therapeutic | Department of Medicine<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.med.unc.edu\/medicine\/news\/ridgeback-merck-announce-preliminary-data-of-potential-covid-19-therapeutic\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Ridgeback, Merck Announce Preliminary Data of Potential COVID-19 Therapeutic | Department of Medicine\" \/>\n<meta property=\"og:description\" content=\"The findings reported on a secondary objective to reduce time to negative test result of infectious SARS-CoV-2 virus in individuals with symptomatic COVID-19. UNC School of Medicine\u2019s William Fischer, MD, is the lead investigator on the study of Molnupiravir, the investigational drug also known as EIDD-2801. Merck and Ridgeback Biotherapeutics announced preliminary results from Ridgeback\u2019s &hellip; Read more\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.med.unc.edu\/medicine\/news\/ridgeback-merck-announce-preliminary-data-of-potential-covid-19-therapeutic\/\" \/>\n<meta property=\"og:site_name\" content=\"Department of Medicine\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/UNCDeptMedicine\" \/>\n<meta property=\"article:published_time\" content=\"2021-03-10T21:01:21+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-06-06T22:07:17+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.med.unc.edu\/medicine\/wp-content\/uploads\/sites\/945\/2018\/12\/william-fischer.jpeg\" \/>\n\t<meta property=\"og:image:width\" content=\"347\" \/>\n\t<meta property=\"og:image:height\" content=\"400\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Kim Morris\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@uncdeptmedicine\" \/>\n<meta name=\"twitter:site\" content=\"@uncdeptmedicine\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Kim Morris\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.med.unc.edu\/medicine\/news\/ridgeback-merck-announce-preliminary-data-of-potential-covid-19-therapeutic\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.med.unc.edu\/medicine\/news\/ridgeback-merck-announce-preliminary-data-of-potential-covid-19-therapeutic\/\"},\"author\":{\"name\":\"Kim Morris\",\"@id\":\"https:\/\/www.med.unc.edu\/medicine\/#\/schema\/person\/9a358414a53d5237f9ba3f8daa55c529\"},\"headline\":\"Ridgeback, Merck Announce Preliminary Data of Potential COVID-19 Therapeutic\",\"datePublished\":\"2021-03-10T21:01:21+00:00\",\"dateModified\":\"2023-06-06T22:07:17+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.med.unc.edu\/medicine\/news\/ridgeback-merck-announce-preliminary-data-of-potential-covid-19-therapeutic\/\"},\"wordCount\":250,\"image\":{\"@id\":\"https:\/\/www.med.unc.edu\/medicine\/news\/ridgeback-merck-announce-preliminary-data-of-potential-covid-19-therapeutic\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.med.unc.edu\/medicine\/wp-content\/uploads\/sites\/945\/2018\/12\/william-fischer.jpeg\",\"keywords\":[\"2021\"],\"articleSection\":[\"News\",\"Pulmonary Diseases and Critical Care Medicine\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.med.unc.edu\/medicine\/news\/ridgeback-merck-announce-preliminary-data-of-potential-covid-19-therapeutic\/\",\"url\":\"https:\/\/www.med.unc.edu\/medicine\/news\/ridgeback-merck-announce-preliminary-data-of-potential-covid-19-therapeutic\/\",\"name\":\"Ridgeback, Merck Announce Preliminary Data of Potential COVID-19 Therapeutic | Department of Medicine\",\"isPartOf\":{\"@id\":\"https:\/\/www.med.unc.edu\/medicine\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.med.unc.edu\/medicine\/news\/ridgeback-merck-announce-preliminary-data-of-potential-covid-19-therapeutic\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.med.unc.edu\/medicine\/news\/ridgeback-merck-announce-preliminary-data-of-potential-covid-19-therapeutic\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.med.unc.edu\/medicine\/wp-content\/uploads\/sites\/945\/2018\/12\/william-fischer.jpeg\",\"datePublished\":\"2021-03-10T21:01:21+00:00\",\"dateModified\":\"2023-06-06T22:07:17+00:00\",\"author\":{\"@id\":\"https:\/\/www.med.unc.edu\/medicine\/#\/schema\/person\/9a358414a53d5237f9ba3f8daa55c529\"},\"breadcrumb\":{\"@id\":\"https:\/\/www.med.unc.edu\/medicine\/news\/ridgeback-merck-announce-preliminary-data-of-potential-covid-19-therapeutic\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.med.unc.edu\/medicine\/news\/ridgeback-merck-announce-preliminary-data-of-potential-covid-19-therapeutic\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.med.unc.edu\/medicine\/news\/ridgeback-merck-announce-preliminary-data-of-potential-covid-19-therapeutic\/#primaryimage\",\"url\":\"https:\/\/www.med.unc.edu\/medicine\/wp-content\/uploads\/sites\/945\/2018\/12\/william-fischer.jpeg\",\"contentUrl\":\"https:\/\/www.med.unc.edu\/medicine\/wp-content\/uploads\/sites\/945\/2018\/12\/william-fischer.jpeg\",\"width\":347,\"height\":400,\"caption\":\"William Fischer, MD\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.med.unc.edu\/medicine\/news\/ridgeback-merck-announce-preliminary-data-of-potential-covid-19-therapeutic\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.med.unc.edu\/medicine\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Ridgeback, Merck Announce Preliminary Data of Potential COVID-19 Therapeutic\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.med.unc.edu\/medicine\/#website\",\"url\":\"https:\/\/www.med.unc.edu\/medicine\/\",\"name\":\"Department of Medicine\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.med.unc.edu\/medicine\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.med.unc.edu\/medicine\/#\/schema\/person\/9a358414a53d5237f9ba3f8daa55c529\",\"name\":\"Kim Morris\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.med.unc.edu\/medicine\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/95c34b3e4d55a602b94260bccc6350c2ddfdde901530a734fe6c8fa9e3a5d399?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/95c34b3e4d55a602b94260bccc6350c2ddfdde901530a734fe6c8fa9e3a5d399?s=96&d=mm&r=g\",\"caption\":\"Kim Morris\"},\"description\":\"Medicine - Dept of\",\"url\":\"https:\/\/www.med.unc.edu\/medicine\/news\/author\/kcmorris\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Ridgeback, Merck Announce Preliminary Data of Potential COVID-19 Therapeutic | Department of Medicine","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.med.unc.edu\/medicine\/news\/ridgeback-merck-announce-preliminary-data-of-potential-covid-19-therapeutic\/","og_locale":"en_US","og_type":"article","og_title":"Ridgeback, Merck Announce Preliminary Data of Potential COVID-19 Therapeutic | Department of Medicine","og_description":"The findings reported on a secondary objective to reduce time to negative test result of infectious SARS-CoV-2 virus in individuals with symptomatic COVID-19. UNC School of Medicine\u2019s William Fischer, MD, is the lead investigator on the study of Molnupiravir, the investigational drug also known as EIDD-2801. Merck and Ridgeback Biotherapeutics announced preliminary results from Ridgeback\u2019s &hellip; Read more","og_url":"https:\/\/www.med.unc.edu\/medicine\/news\/ridgeback-merck-announce-preliminary-data-of-potential-covid-19-therapeutic\/","og_site_name":"Department of Medicine","article_publisher":"https:\/\/www.facebook.com\/UNCDeptMedicine","article_published_time":"2021-03-10T21:01:21+00:00","article_modified_time":"2023-06-06T22:07:17+00:00","og_image":[{"width":347,"height":400,"url":"https:\/\/www.med.unc.edu\/medicine\/wp-content\/uploads\/sites\/945\/2018\/12\/william-fischer.jpeg","type":"image\/jpeg"}],"author":"Kim Morris","twitter_card":"summary_large_image","twitter_creator":"@uncdeptmedicine","twitter_site":"@uncdeptmedicine","twitter_misc":{"Written by":"Kim Morris","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.med.unc.edu\/medicine\/news\/ridgeback-merck-announce-preliminary-data-of-potential-covid-19-therapeutic\/#article","isPartOf":{"@id":"https:\/\/www.med.unc.edu\/medicine\/news\/ridgeback-merck-announce-preliminary-data-of-potential-covid-19-therapeutic\/"},"author":{"name":"Kim Morris","@id":"https:\/\/www.med.unc.edu\/medicine\/#\/schema\/person\/9a358414a53d5237f9ba3f8daa55c529"},"headline":"Ridgeback, Merck Announce Preliminary Data of Potential COVID-19 Therapeutic","datePublished":"2021-03-10T21:01:21+00:00","dateModified":"2023-06-06T22:07:17+00:00","mainEntityOfPage":{"@id":"https:\/\/www.med.unc.edu\/medicine\/news\/ridgeback-merck-announce-preliminary-data-of-potential-covid-19-therapeutic\/"},"wordCount":250,"image":{"@id":"https:\/\/www.med.unc.edu\/medicine\/news\/ridgeback-merck-announce-preliminary-data-of-potential-covid-19-therapeutic\/#primaryimage"},"thumbnailUrl":"https:\/\/www.med.unc.edu\/medicine\/wp-content\/uploads\/sites\/945\/2018\/12\/william-fischer.jpeg","keywords":["2021"],"articleSection":["News","Pulmonary Diseases and Critical Care Medicine"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.med.unc.edu\/medicine\/news\/ridgeback-merck-announce-preliminary-data-of-potential-covid-19-therapeutic\/","url":"https:\/\/www.med.unc.edu\/medicine\/news\/ridgeback-merck-announce-preliminary-data-of-potential-covid-19-therapeutic\/","name":"Ridgeback, Merck Announce Preliminary Data of Potential COVID-19 Therapeutic | Department of Medicine","isPartOf":{"@id":"https:\/\/www.med.unc.edu\/medicine\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.med.unc.edu\/medicine\/news\/ridgeback-merck-announce-preliminary-data-of-potential-covid-19-therapeutic\/#primaryimage"},"image":{"@id":"https:\/\/www.med.unc.edu\/medicine\/news\/ridgeback-merck-announce-preliminary-data-of-potential-covid-19-therapeutic\/#primaryimage"},"thumbnailUrl":"https:\/\/www.med.unc.edu\/medicine\/wp-content\/uploads\/sites\/945\/2018\/12\/william-fischer.jpeg","datePublished":"2021-03-10T21:01:21+00:00","dateModified":"2023-06-06T22:07:17+00:00","author":{"@id":"https:\/\/www.med.unc.edu\/medicine\/#\/schema\/person\/9a358414a53d5237f9ba3f8daa55c529"},"breadcrumb":{"@id":"https:\/\/www.med.unc.edu\/medicine\/news\/ridgeback-merck-announce-preliminary-data-of-potential-covid-19-therapeutic\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.med.unc.edu\/medicine\/news\/ridgeback-merck-announce-preliminary-data-of-potential-covid-19-therapeutic\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.med.unc.edu\/medicine\/news\/ridgeback-merck-announce-preliminary-data-of-potential-covid-19-therapeutic\/#primaryimage","url":"https:\/\/www.med.unc.edu\/medicine\/wp-content\/uploads\/sites\/945\/2018\/12\/william-fischer.jpeg","contentUrl":"https:\/\/www.med.unc.edu\/medicine\/wp-content\/uploads\/sites\/945\/2018\/12\/william-fischer.jpeg","width":347,"height":400,"caption":"William Fischer, MD"},{"@type":"BreadcrumbList","@id":"https:\/\/www.med.unc.edu\/medicine\/news\/ridgeback-merck-announce-preliminary-data-of-potential-covid-19-therapeutic\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.med.unc.edu\/medicine\/"},{"@type":"ListItem","position":2,"name":"Ridgeback, Merck Announce Preliminary Data of Potential COVID-19 Therapeutic"}]},{"@type":"WebSite","@id":"https:\/\/www.med.unc.edu\/medicine\/#website","url":"https:\/\/www.med.unc.edu\/medicine\/","name":"Department of Medicine","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.med.unc.edu\/medicine\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.med.unc.edu\/medicine\/#\/schema\/person\/9a358414a53d5237f9ba3f8daa55c529","name":"Kim Morris","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.med.unc.edu\/medicine\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/95c34b3e4d55a602b94260bccc6350c2ddfdde901530a734fe6c8fa9e3a5d399?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/95c34b3e4d55a602b94260bccc6350c2ddfdde901530a734fe6c8fa9e3a5d399?s=96&d=mm&r=g","caption":"Kim Morris"},"description":"Medicine - Dept of","url":"https:\/\/www.med.unc.edu\/medicine\/news\/author\/kcmorris\/"}]}},"featured_image":"https:\/\/www.med.unc.edu\/medicine\/wp-content\/uploads\/sites\/945\/2018\/12\/william-fischer.jpeg","featured_image_medium":"https:\/\/www.med.unc.edu\/medicine\/wp-content\/uploads\/sites\/945\/2018\/12\/william-fischer-260x300.jpeg","featured_image_medium_large":"https:\/\/www.med.unc.edu\/medicine\/wp-content\/uploads\/sites\/945\/2018\/12\/william-fischer.jpeg","featured_image_large":"https:\/\/www.med.unc.edu\/medicine\/wp-content\/uploads\/sites\/945\/2018\/12\/william-fischer.jpeg","featured_image_thumbnail":"https:\/\/www.med.unc.edu\/medicine\/wp-content\/uploads\/sites\/945\/2018\/12\/william-fischer-150x150.jpeg","featured_image_alt":"william-fischer-experimental-pill-treat-COVID","category_details":[{"name":"News","link":"https:\/\/www.med.unc.edu\/medicine\/news\/category\/news\/"},{"name":"Pulmonary Diseases and Critical Care Medicine","link":"https:\/\/www.med.unc.edu\/medicine\/news\/category\/pulmonary\/"}],"tag_details":[{"name":"2021","link":"https:\/\/www.med.unc.edu\/medicine\/news\/tag\/2021\/"}],"_links_to":[],"_links_to_target":[],"_links":{"self":[{"href":"https:\/\/www.med.unc.edu\/medicine\/wp-json\/wp\/v2\/posts\/50031","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.med.unc.edu\/medicine\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.med.unc.edu\/medicine\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.med.unc.edu\/medicine\/wp-json\/wp\/v2\/users\/69419"}],"replies":[{"embeddable":true,"href":"https:\/\/www.med.unc.edu\/medicine\/wp-json\/wp\/v2\/comments?post=50031"}],"version-history":[{"count":0,"href":"https:\/\/www.med.unc.edu\/medicine\/wp-json\/wp\/v2\/posts\/50031\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.med.unc.edu\/medicine\/wp-json\/wp\/v2\/media\/5986"}],"wp:attachment":[{"href":"https:\/\/www.med.unc.edu\/medicine\/wp-json\/wp\/v2\/media?parent=50031"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.med.unc.edu\/medicine\/wp-json\/wp\/v2\/categories?post=50031"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.med.unc.edu\/medicine\/wp-json\/wp\/v2\/tags?post=50031"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}